CNBC's Jim Cramer on Thursday recommended that investors not base portfolio decisions solely off of macro economic trends, like new employment data or interest rates.
He discussed pharmaceutical giant Eli Lilly's blow-out quarter, saying its success is not due to general attitudes on the market.on Thursday recommended that investors not base portfolio decisions solely off macroeconomic trends, like new employment data or interest rates."I don't want to be bound by the four walls of the PMIs, the PPIs, the PCDEs, the GDPs.
was not due to mortgage rates or other macro factors. He said the quarter shows that Eli Lilly is ahead of its competitors when it comes to drug formulations and the ability to scale manufacturing. Cramer reiterated his long-held belief that it's prudent to invest in good companies and hold onto their shares as long as business seems solid.
"If you pay attention to the real world, you may find yourself taking a GLP-1 and want to buy the stock of Eli Lilly," he said."But if you pay too much attention to the financial world, you might've convinced yourself that this stock wasn't worth owning."Sign up for our free Olympics Headlines newsletter.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: Investingcom - 🏆 450. / 53 Consulte Mais informação »